Lv31
310 积分 2022-04-11 加入
Current perspectives of KRAS in non-small cell lung cancer
5天前
已完结
Targeting the incretin system in obesity and type 2 diabetes mellitus
20天前
已完结
[Chinese expert consensus of albumin-bound paclitaxel in the treatment of breast cancer]
20天前
已完结
[Comprehensive application of various screening strategies of Lynch syndrome]
27天前
已关闭
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
1个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
1个月前
已完结
Comparison of clinical effects of the high depot of goserelin acetate with the conventional depot in patients with advanced prostate cancer
2个月前
已完结
[Multidisciplinary expert consensus on the clinical rational application of different formulations of amphotericin B (2024 edition)]
2个月前
已完结
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
2个月前
已完结
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
2个月前
已完结
皖公网安备34019202002308
